DPYSL5 and breast carcinoma: 2 (lung or breast cancer), anti-Ma2 (lung, breast, or testicular cancer), anti-CV2/CRMP5 (small cell lung cancer), and anti-amphiphysin (breast, small cell lung cancer) (34,35).